SERA vs ZION · rev $81.0K vs P/E 11, rev $354.0M
Sera Prognostics Inc (SERA) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported SERA revenue for 2025-12-31 was $81.0K. Net income was -$31.9M. SERA currently screens at market cap $89.1M.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
SERA currently screens at market cap $89.1M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the SERA and ZION stock pages for the full models.
Not investment advice.